Determining the point of indifference--where costs of selective and universal immunization against hepatitis B are identical, in a cost-minimization exercise.
Varghese
R Mathew
RM
Abraham
Jacob
J
James
Jyotsna
J
Puliyel
Jacob M
JM
D000328:Adult; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D005260:Female; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000191:economics*; D019694:Hepatitis B, Chronic / Q000151:congenital / Q000635:transmission; D006801:Humans; D017589:Immunization Programs / Q000191:economics* / Q000592:standards*; D007194:India; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D018579:Patient Selection; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D018570:Risk Assessment
D017325:Hepatitis B Vaccines